HOOKIPA Pharma Inc.
NASDAQ:HOOK
3.76 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | HOOKIPA Pharma Inc. |
Symbool | HOOK |
Munteenheid | USD |
Prijs | 3.76 |
Beurswaarde | 45,325,067 |
Dividendpercentage | 0% |
52-weken bereik | 3.415 - 11.3 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joern Aldag |
Website | https://www.hookipapharma.com |
An error occurred while fetching data.
Over HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)